The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hematologic toxicity in 177lu-PSMA-617 treatment for mCRPC: Unraveling the impact of PSMA PET bone tumor volume (PSMA-bTTV).
 
Alireza Ghodsi
No Relationships to Disclose
 
Ridvan Arda Demirci
No Relationships to Disclose
 
Roman Gulati
Employment - Linda Fukuda Family Dentistry (I)
 
Ruben Raychaudhuri
No Relationships to Disclose
 
Heather H. Cheng
Consulting or Advisory Role - AstraZeneca; AstraZeneca (I)
Research Funding - Clovis Oncology (Inst); Color Genomics Foundation (Inst); Janssen (Inst); Medivation/Astellas (Inst); Phosplatin Therapeutics (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
Other Relationship - Janssen
 
Jessica E. Hawley
Consulting or Advisory Role - Daiichi Sankyo/Lilly; ImmunityBio
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb/Celgene (Inst); Crescendo Biologics (Inst); Janssen Oncology (Inst); Macrogenics (Inst); Vaccitech (Inst)
 
Todd Yezefski
Honoraria - Pfizer/Myovant
Consulting or Advisory Role - Dendreon
 
Michael C. Haffner
Research Funding - Merck
 
Robert Bruce Montgomery
Consulting or Advisory Role - Daiichi Sankyo/UCB Japan
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Beigene (Inst); Clovis Oncology (Inst); Janssen Oncology (Inst)
 
Peter Nelson
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen Oncology; Pfizer
Research Funding - Janssen Oncology
Expert Testimony - Venable
 
Michael Thomas Schweizer
Consulting or Advisory Role - AstraZeneca; FibroGen; Janssen; Pfizer; Sanofi
Research Funding - Ambrx (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Epigenetix (Inst); Immunomedics (Inst); Incyte (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); SignalOne Bio (Inst); Tmunity Therapeutics, Inc. (Inst); Xencor (Inst); Zenith Epigenetics (Inst)
 
Evan Y. Yu
Consulting or Advisory Role - AADi; Advanced Accelerator Applications; Bayer; Bristol Myers Squibb; Janssen; Loxo/Lilly; Merck; Oncternal Therapeutics
Research Funding - Bayer (Inst); Blue Earth Diagnostics (Inst); Daiichi Sankyo (Inst); Dendreon (Inst); Lantheus Medical Imaging (Inst); Merck (Inst); Seagen (Inst); Surface Oncology (Inst); Taiho Pharmaceutical (Inst); Tyra Biosciences (Inst)
 
Delphine L. Chen
Honoraria - GE Healthcare; Telix Pharmaceuticals
Research Funding - Telix Pharmaceuticals (Inst); United Imaging (Inst)
Patents, Royalties, Other Intellectual Property - WO 201503526 A1 Mach RH, Chu W, Zhou D, Michel LS, Chen DL. Radiolabeled tracers for poly(adp-ribose)polymerase-1 (PARP-1), methods and uses therfor
Travel, Accommodations, Expenses - GE Healthcare
 
Amir Iravani
No Relationships to Disclose